Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review

March 2021 | 60 pages | ID: IE5BEFD627DEN
GlobalData

Abstracts

Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. The company’s product pipeline includes VGX-3100 for the treatment of cervical HSIL, vulvar HSIL, anal HSIL; INO-5401for glioblastoma; INO-3107 for recurrent respiratory papillomatosis (RRP); MEDI0457 for head and neck cancer and INO-5151 for the treatment of Prostate cancer. The company also has platform development programs in partnerships with several companies and government bodies focused at developing therapeutics for infectious diseases such as HIV, ebola, zika virus, middle east respiratory syndrome (MERS), lassa fever and COVID-19 disease. Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals Inc Key Recent Developments

Mar 15,2021: INOVIO announces the appointment of Michael Cordera as Executive Vice President & General Counsel
Mar 01,2021: INOVIO reports fourth quarter 2020 and year-end financial results
Feb 16,2021: INOVIO to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
Dec 04,2020: Inovio enters Covid-19 vaccine development deal with Kaneka Eurogentec
Nov 09,2020: INOVIO reports third quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Inovio Pharmaceuticals Inc - Key Facts
Inovio Pharmaceuticals Inc - Key Employees
Inovio Pharmaceuticals Inc - Key Employee Biographies
Inovio Pharmaceuticals Inc - Major Products and Services
Inovio Pharmaceuticals Inc - History
Inovio Pharmaceuticals Inc - Company Statement
Inovio Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Inovio Pharmaceuticals Inc - Business Description
Inovio Pharmaceuticals Inc - Corporate Strategy
Inovio Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Inovio Pharmaceuticals Inc - Strengths
Inovio Pharmaceuticals Inc - Weaknesses
Inovio Pharmaceuticals Inc - Opportunities
Inovio Pharmaceuticals Inc - Threats
Inovio Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Inovio Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 15, 2021: INOVIO announces the appointment of Michael Cordera as Executive Vice President & General Counsel
Mar 01, 2021: INOVIO reports fourth quarter 2020 and year-end financial results
Feb 16, 2021: INOVIO to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
Dec 04, 2020: Inovio enters Covid-19 vaccine development deal with Kaneka Eurogentec
Nov 09, 2020: INOVIO reports third quarter 2020 financial results
Aug 10, 2020: INOVIO reports second quarter 2020 financial results; provides DNA medicines clinical program mid-year update
Jun 04, 2020: VGXI’s Statement on the Recent Litigation Involving Inovio Pharmaceuticals in Pennsylvania State Court
May 26, 2020: INOVIO to host webinar 'DNA Medicines: From COVID-19 to Cancer'
May 11, 2020: INOVIO reports first quarter 2020 financial results; provides business update
Apr 02, 2020: Australia’s CSIRO starts first stage of coronavirus vaccine testing

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Inovio Pharmaceuticals Inc, Key Facts
Inovio Pharmaceuticals Inc, Key Employees
Inovio Pharmaceuticals Inc, Key Employee Biographies
Inovio Pharmaceuticals Inc, Major Products and Services
Inovio Pharmaceuticals Inc, History
Inovio Pharmaceuticals Inc, Other Locations
Inovio Pharmaceuticals Inc, Subsidiaries
Inovio Pharmaceuticals Inc, Key Competitors
Inovio Pharmaceuticals Inc, Ratios based on current share price
Inovio Pharmaceuticals Inc, Annual Ratios
Inovio Pharmaceuticals Inc, Annual Ratios (Cont...1)
Inovio Pharmaceuticals Inc, Interim Ratios
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Inovio Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Inovio Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Inovio Pharmaceuticals Inc, Ratio Charts
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021